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Abstract	
This	study	characterizes	the	impact	of	increasing-intensity	treadmill	exercise	(iTR)	
on	 noradrenergic	 (NE)	 and	 serotonergic	 (5HT)	 modulation	 of	 neuropathic	 pain.	
Following	 sciatic	 nerve	 transection	 and	 repair	 (SNTR)	 rats	 developed	 significant	
mechanical	 and	 thermal	 hyperalgesia	 that	was	 partially	 prevented	by	 iTR	 performed	
during	the	first	2	weeks	after	injury.		
Marked	decrease	in	the	expression	of	5HT2A	and	α1A	and	β-,	but	not	α2A	adrenergic	
receptors	in	the	spinal	cord	dorsal	horn	was	associated	to	SNTR	and	recovered	by	iTR,	
particularly	in	lamina	II.	iTR	significantly	increased	5HT2A	in	periaqueductal	grey	(PAG),	
raphe	 magnus	 (RM)	 and	 dorsal	 raphe	 nucleus	 (DRN),	 with	 a	 pattern	 suggesting	
reorganization	of	serotonergic	excitatory	interconnections	between	PAG	and	DRN.	iTR	
also	 increased	 the	 expression	 of	 α1A	 in	 locus	 coeruleus	 (LC)	 and	 DRN,	 and	 β2	 in	 LC,	
indicating	that	exercise	enhanced	activity	of	NE	neurons,	likely	by	activating	autologous	
projections	from	DRN	and	PAG.		
iTR	 hypoalgesia	 was	 antagonized	 by	 blockade	 of	 β2	 and	 5HT2A	 receptors	 with	
administration	 of	 butoxamine	 and	 ketanserin.	 The	 neurotoxin	 DSP4	 was	 injected	 to	
induce	 depletion	 of	 NE	 projections	 from	 LC	 before	 starting	 iTR.	 DSP4	 treatment	
worsened	 mechanical	 hyperalgesia,	 but	 iTR	 hypoalgesia	 was	 similarly	 produced.	
Moreover,	5HT2A	expression	in	LC	further	increased	after	DSP4	injection,	all	these	results	
suggesting	 an	 intrinsic	 regulation	 of	 5HT	 and	NE	 activity	 between	 PAG,	 DRN	 and	 LC	
neurons	activated	by	iTR.		
Finally,	 iTR	 significantly	 reduced	 microglial	 reactivity	 in	 LC	 and	 increased	 non-
microglial	 BDNF	 expression,	 an	 effect	 that	 was	 reverted	 by	 butoxamine,	 implicating	
BDNF	regulation	in	central	5HT/NE	actions	on	neuropathic	pain.	
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1. Introduction	
Increasing-intensity	treadmill	exercise	(iTR),	performed	during	the	first	days	after	
injury,	has	been	shown	to	significantly	reduce	hyperalgesia	in	neuropathic	pain	models,	
such	as	sciatic	nerve	chronic	constriction	injury	(CCI)	(Cobianchi	et	al.,	2010)	and	section	
and	suture	repair	(SNTR)	(Cobianchi	et	al.,	2013).	iTR	decreased	the	expression	of	BDNF	
and	other	neurotrophins	although	without	impairing	nerve	regeneration	(Cobianchi	et	
al.,	 2013,	 Lopez-Alvarez	 et	 al.,	 2015).	 iTR-induced	 decrease	 of	 BDNF	 expression	was	
associated	 to	 reduction	 of	microgliosis	 and	 restoration	 of	 the	 expression	 of	 chloride	
transporters	 in	 the	 primary	 sensory	 neurons	 and	 along	 the	 central	 pain	 pathways	
(Lopez-Alvarez	et	al.,	2015;	Modol	et	al.,	2014).	Little	is	known,	however,	on	the	central	
mechanisms	by	which	iTR	induces	hypoalgesia,	and	we	hypothesize	that	it	may	act	by	
activating	descending	pathways	for	inhibition	of	pain	transmission	at	the	spinal	level.	
Brain	 areas	 can	 modulate	 the	 ascending	 pain	 signals	 by	 serotonergic	 and	
noradrenergic	 projections	 to	 spinal	 cord	 neurons,	 which	 can	 facilitate	 or	 inhibit	 the	
afferent	 sensory	 neurons.	 Periaqueductal	 grey	 (PAG)	 areas	 receive	 pain	 and	
temperature	 fibers	 and	 activate	 defensive	 and	 stress	 responses	 by	 sending	 axons	 to	
both	 locus	 coeruleus	 (LC)	 and	 raphe	 magnus	 nucleus	 (RM),	 whose	 antinociceptive	
output	trigger	descending	inhibition	(Millan,	2002).	Serotonergic	RM	and	noradrenergic	
LC	 projections	 normally	 activate	 spinal	 enkephalinergic	 and	 GABA/glycinergic	
interneurons.	 Enkephalin	 released	 from	 terminals	 of	 enkephalinergic	 dorsal	 horn	
interneurons	 acts	 on	 the	 opioid	 receptors	 located	 on	 the	 central	 processes	 of	
nociceptive	primary	afferents,	reducing	Ca2+	entry	into	their	terminals	and	decreasing	
the	 release	 of	 nociceptive	 neurotransmitters	 such	 as	 glutamate	 and	 substance	 P	
(Ossipov	et	al.,	2010).	Similarly,	activation	of	dorsal	horn	interneurons	containing	GABA	
or	glycine	also	inhibit	the	spinal	transmission	of	noxious	sensory	signals,	and	previous	
studies	 indicate	 that	 spinal	GABAergic	 inhibition	 is	 reduced	after	experimental	nerve	
injury	 (Moore	et	al.,	 2002).	The	 loss	of	 tonic	 inhibition	by	 spinal	 interneurons	 is	also	
associated	 with	 dysregulation	 of	 NKCC1/KCC2	 chloride	 cotransporters	 expression,	
inducing	 an	 inversion	 of	 GABAergic	 depolarizing	 currents	 in	 neuropathic	 conditions	
(Modol	et	al.,	2014),	that	is	prevented	by	iTR	(Lopez-Alvarez	et	al.,	2015).		
Besides	the	demonstrated	peripheral	effects	(Cobianchi	et	al.,	2010,	2013;	Lopez-
Alvarez	et	 al.,	 2015;	Udina	et	al.,	 2011),	we	hypothesized	 that	 iTR	may	activate	pain	
central	 inhibition	normally	gating	the	nociceptive	input	to	supraspinal,	medullary	and	
cortical	 areas,	which	 are	 decreased	 after	 peripheral	 nerve	 injury.	 By	 stimulating	 the	
descending	 noradrenergic	 and	 serotonergic	 projections	 to	 the	 dorsal	 horn,	 specific	
exercise	training	may	result	in	the	activation	of	inhibitory	circuits	in	the	dorsal	horn	and	
in	the	consequent	inhibition	of	second-order	spinothalamic	neurons	by	presynaptic	and	
postsynaptic	mechanisms.	
We	studied	the	expression	of	noradrenaline	(NE)	and	serotonin	(5HT)	receptors	in	
sensory	 neurons	 of	 the	 spinal	 cord	 dorsal	 horn,	 that	 participate	 in	 pain	modulation.	
Among	NE	receptors,	α1A	receptors	are	expressed	in	GABAergic	and	glycinergic	neurons	
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of	dorsal	horn	lamina	II,	where	they	may	participate	in	endogenous	inhibition	of	afferent	
pain	by	exciting	inhibitory	interneurons	(Baba	et	al.,	2000).	α2A	receptors	are	expressed	
in	the	spinal	cord	predominantly	on	the	terminals	of	primary	C-fibers	afferents,	where	
they	inhibit	nociception	(Stone	et	al.,	1998).	β2	receptor	is	an	excitatory	adrenoreceptor	
expressed	 in	 dorsal	 horn	 neurons	 (Nicholson	 et	 al.,	 2005),	 which	 activation	 induces	
antinociceptive	effects	(Yalcin	et	al.,	2009a,b,	2010;	Zhang	et	al.,	2016).	We	also	assessed	
changes	 in	 serotonergic	 5HT2A	 receptor	 since	 it	 is	 involved	 in	 spinal	 chloride	
homeostasis,	which	dysregulation	is	associated	with	spinal	disinhibition	and	neuropathic	
pain	(Gackiere	and	Vinay,	2014;	Jacobs	et	al.,	2002).	Under	hyperalgesic	states	the	5HT2A	
receptor	was	found	to	be	expressed	in	 laminae	I-III	NK1R-positive	projection	neurons	
(Mantyh	et	al.,	1997)	and	in	lamina	II	galanin-containing	neurons	expressing	GABAergic	
boutons	(Tiong	et	al.,	2011),	receiving	emerging	interest	as	a	potential	target	for	treating	
nerve	injury-induced	pain	and	spasticity	(Bos	et	al.,	2013).	
In	 this	 study,	we	 investigated	 the	 changes	 induced	by	 iTR	on	noradrenergic	 and	
serotonergic	 circuitry	 that	 may	 be	 related	 to	 antinociception.	 For	 this	 purpose,	 we	
analyzed	the	expression	of	adrenergic	α1A,	α2A	and	β2	receptors,	and	serotonergic	5HT2A	
receptor	after	 injury	 to	 the	 sciatic	nerve	 in	 rats,	 and	 their	 changes	under	 increasing-
intensity	 exercise	when	 neuropathic	 pain	 is	 prevented.	We	 also	 relate	 the	 exercise-
induced	hypoalgesia	to	the	expression	of	β2	receptor	and	the	reduction	of	microgliosis	
in	noradrenergic	neurons.	
	
2. Materials	and	methods	
	
2.1. Animals	and	surgery	
Adult	female	Sprague-Dawley	rats	(240	±	30	g)	were	housed	in	standard	cages	with	
access	 to	 food	 and	 water	 ad	 libitum	 under	 a	 light–dark	 cycle	 of	 12	 hours.	 All	 the	
experimental	 procedures	were	 approved	by	 the	 Ethics	 Committee	of	 the	Universitat	
Autonoma	de	Barcelona	and	followed	the	guidelines	of	the	European	Commission	on	
Animal	Care	(EU	Directive	2010/63/EU).	Rats	were	anesthetized	by	intraperitoneal	(i.p.)	
injection	 of	 ketamine	 (10	 mg/kg,	 Imalgene	 500;	 Rhone-Merieux,	 Lyon,	 France)	 and	
xylazine	(1	mg/kg,	Rompun;	Bayer,	Leverkusen,	Germany).		
Rats	 were	 submitted	 to	 a	 sciatic	 nerve	 transection	 and	 repair	 (SNTR),	 a	 well	
characterized	 model	 that	 allows	 the	 evaluation	 of	 neuropathic	 pain	 and	 nerve	
regeneration	 (Cobianchi	et	al.,	2014).	The	right	sciatic	nerve	was	exposed	at	 the	mid	
thigh,	 transected	 at	 92	mm	 from	 the	 tip	 of	 the	 third	 toe,	 and	 repaired	by	 epineural	
sutures	 (10-0).	 The	 wound	 was	 closed	 in	 two	 layers	 and	 disinfected	 with	 povidone	
iodine.	Rats	were	kept	in	a	warm	environment	until	their	recovery	from	anesthesia.		
	
2.2. Experimental	design	
Seven	days	before	 surgery,	 all	 the	animals	were	habituated	 to	 the	experimental	
device	 for	 treadmill	 locomotion	 (Treadmill	 LE	 8706;	 LETICA,	 Barcelona,	 Spain)	 and	
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pretrained	to	the	task,	by	leaving	them	to	explore	the	stopped	treadmill	for	5	minutes	
and	then	trained	in	a	single	iTR	session.	Each	iTR	session	consisted	of	1	hour	running,	
starting	at	a	locomotion	speed	of	10	cm/s	that	was	increased	2	cm/s	every	5	minutes,	
until	a	maximal	speed	of	32	cm/s	(Cobianchi	et	al.,	2013;	Lopez-Alvarez	et	al.,	2015).	All	
rats	were	evaluated	during	follow-up	with	sensory	tests	performed	during	the	morning,	
whereas	treadmill	running	sessions	were	performed	during	the	afternoon.	
At	day	3	after	 surgery,	 animals	were	 randomly	 selected	 to	 follow	or	not	 the	 iTR	
training.	Training	sessions	were	performed	daily	over	12	consecutive	days	from	day	3	to	
14	after	injury.			
SNTR	rats	were	divided	in	several	groups:	a	group	of	rats	performed	iTR	(SNTR-iTR	
group,	n=10),	and	a	 second	group	 remained	sedentary	 (SNTR-sed	group,	n=8).	Other	
groups	 performed	 or	 not	 iTR	 with	 pharmacological	 blockade	 of	 β2-receptors	 with	
butoxamine	(Sigma-Aldrich,	8	mg/Kg	in	saline,	i.p.;	SNTR-iTR+Bu	group,	n=6,	and	SNTR-
sed+Bu	group,	n=6),	or	blockade	of	5HT2A-receptors	with	ketanserin	(Sigma-Aldrich,	8	
mg/Kg	 in	 saline,	 i.p.;	 SNTR-sed+Ke	 group,	 n=6,	 and	 SNTR-iTR+Ke	 group,	 n=6).	 These	
drugs	were	administered	each	day	of	training,	30	minutes	before	starting	the	exercise.	
Doses	were	chosen	over	the	basis	of	previous	studies	using	rats.	Control	groups	for	both	
drugs	 were	 injected	 with	 saline	 vehicle	 only.	 A	 naive	 group	 of	 rats	 was	 added	 for	
comparison	with	injured	rats	(n=6).Finally,	other	two	groups	of	animals	were	injected	
with	N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine	(DSP4,	Sigma-Aldrich,	50	mg/kg	in	
saline,	i.p.),	a	neurotoxin	that	selectively	induces	degeneration	of	NE	neurons	in	the	LC,	
thus	depleting	NE	projections	originating	from	the	LC	(Jonsson	et	al.,	1981;	Prieto	and	
Giralt,	2001).	DSP-4	was	injected	within	10	min	of	preparation	(Grzanna	et	al.,	1989),	
and	its	administration	was	performed	4	days	before	the	injury	to	ensure	effect	from	the	
beginning	of	the	training.	One	group	of	DSP4	injected	rats	followed	iTR	(SNTR-iTR+DSP4	
group,	n=8),	and	another	remained	untrained	(SNTR+DSP4	group,	n=10).		
	
2.3. Nociceptive	tests	for	pain	threshold	measurement	
Three	 days	 before	 surgery,	 all	 the	 injured	 animals	 were	 habituated	 to	 the	
experimental	devices,	 and	 then	 tested	 for	baseline	nociceptive	 thresholds	 recording.	
The	nociceptive	behavior	tests	for	mechanical	and	thermal	stimuli	were	performed	on	
both	hind	paws	before	and	at	different	days	after	injury	(dpi),	the	experimenter	being	
blind	to	assignment	of	rats	to	the	different	groups.	Lateral	and	medial	sites	of	the	paw	
were	 tested	 to	 differentiate	 changes	 in	 sensory	 thresholds	 produced	 respectively	 by	
sciatic	 nerve	 injury	 from	 those	 due	 to	 saphenous	 nerve	 sprouting	 (Cobianchi	 et	 al.,	
2014).		
Sensitivity	to	mechanical	stimuli	was	measured	by	means	of	an	electronic	Von	Frey	
algesimeter	(Bioseb,	Chaville,	France).	Rats	were	placed	on	a	wire	net	platform	in	plastic	
chambers.	 Then,	 a	 non-noxious	 pointed	 probe	was	 gently	 applied	 to	 each	 test	 site,	
slowly	increasing	the	pressure.	The	threshold	was	expressed	as	the	force	(in	grams)	at	
which	rats	withdrew	the	paw	in	response	to	the	stimulus.	A	cutoff	force	was	set	at	40	g,	
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when	 the	 stimulus	 lifted	 the	 paw	 without	 response.	 The	 mechanical	 nociceptive	
threshold	was	calculated	as	the	mean	of	3	measurements	per	test	site,	with	a	3	minute	
interval	between	each	measurement.		
Thermal	sensitivity	was	assessed	by	means	of	a	Plantar	test	algesimeter	(Ugo	Basile,	
Comerio,	Italy).	Rats	were	placed	into	a	plastic	box	with	an	elevated	plexiglass	floor.	The	
beam	of	a	 lamp	was	pointed	at	the	same	test	sites	as	above	 in	the	hind	paw	plantar	
surface.	Intensity	was	set	to	low	power	(40	mW/cm2)	with	a	slow	heating	rate.	A	cutoff	
time	for	the	stimuli	was	set	at	20	seconds	to	prevent	tissue	damage.	Heat	pain	threshold	
was	calculated	as	the	mean	of	3	trials	per	test	site,	with	a	5	minute	interval	between	
trials,	and	expressed	as	the	latency	(in	seconds)	of	paw	withdrawal	response.	For	both	
mechanical	 and	 thermal	 thresholds,	 values	 are	 reported	 as	 the	 percentage	 ratio	
between	the	ipsilateral	injured	and	the	contralateral	normal	paw	at	each	test	day.	This	
allows	a	representation	of	neuropathic	pain	induced	by	the	injury	since	no	significant	
variations	of	contralateral	thresholds	were	found	in	previous	studies	(Cobianchi	et	al.,	
2013;	Lopez-Alvarez	et	al.,	2015).	
	
2.4. Immunohistochemistry	of	spinal	cord	and	brain	
At	the	end	of	follow-up	at	14	dpi,	all	rats	were	euthanized	and	spinal	cord	and	brain	
samples	collected	for	immunohistochemical	assays.	Lumbar	(L4-L5)	spinal	cord	segment	
and	brain	were	removed	from	perfused	animals	and	kept	 in	fixative	for	1	hour	and	4	
hours	 respectively,	 and	 then	 cryoprotected	 with	 30%	 sucrose	 in	 PBS.	 Transverse	
sections,	 25	µm	 thick,	were	 cut	on	a	 cryostat	 and	mounted	on	 slides.	 Sections	were	
blocked	with	specific	serum	and	incubated	overnight	with	primary	antibodies	in	0.3%	
Triton	X-100	 in	PBS,	used	 for	 staining	5HT	and	NE	 receptors	 in	 spinal	 cord	and	brain	
sections	 (anti-β2	 receptors,	 rabbit,	 1:500,	 Santa	Cruz;	 anti-α1A	receptors,	 goat,	 1:500,	
Santa	Cruz;	anti-α2A	receptors,	goat,	1:500,	Santa	Cruz;	anti-5HT2A	receptors,	goat,	1:500,	
Santa	 Cruz),	 along	 with	 antibodies	 to	 identify	 5HT	 and	 NE	 neurons	 (anti-tyrosin	
hydroxylase	(TH),	mouse,	1:500,	Santa	Cruz;	anti-tryptophan	hydroxylase	(TPH),	mouse,	
1:500,	Santa	Cruz),	microglial	cells	(anti-Iba1,	goat,	1:200,	Abcam)	and	BDNF	(anti-BDNF,	
sheep,	1:200,	Millipore).		
The	following	day	sections	were	incubated	for	2	hours	with	Alexa	Fluor	488	and/or	
Alexa	 Fluor	 594	 conjugated	 secondary	 antibodies	 (1:200,	 Life	 Technologies).	 After	
washing	in	PBS,	sections	were	coverslipped	with	a	solution	of	DAPI	(1	mL/mL)	in	Mowiol	
mounting	 medium.	 Positive	 and	 negative	 controls	 of	 antibodies	 were	 previously	
checked	for	non-specific	labeling.	For	each	marker,	three	sections	from	4	samples	per	
group	were	used	for	quantification	of	immunolabeling.	The	experimenter	was	blinded	
to	the	sample	group.	Anatomical	structures	of	interest	were	previously	identified	under	
microscope	in	spinal	cord	and	brain	atlas	coordinates	using	specific	sections	and	Nissl	or	
Hematoxylin	staining.	10X	and	20X	images	were	captured	with	a	Zeiss	LSM	700	confocal	
microscope,	and	analyzed	using	ImageJ	software	(NIH,	USA).	Thresholding	of	fluorescent	
signal	was	adjusted	over	the	background	 level	of	a	negative	control	 (samples	stained	
7	
	
without	primary	antibody).	The	integrated	density	of	immunoreactivity	was	calculated	
within	 regions	 of	 interest	 drawn	 with	 ImageJ	 software	 tool.	 For	 spinal	 cord	
immunoreactivity,	data	are	shown	for	both	ipsilateral	and	contralateral	sides.	For	brain	
immunoreactivity,	data	are	shown	only	for	projection	areas	of	the	injured	side.		
	
2.5. Data	analysis	
Data	are	presented	as	mean	±	SEM.	Statistical	analysis	of	nociceptive	thresholds	was	
made	 by	 two-way	 analysis	 of	 variance	 (ANOVA)	with	 group	 and	 time	 after	 injury	 as	
factors,	 followed	 by	 Bonferroni’s	 post	 hoc	 comparisons.	 Statistical	 comparisons	 for	
immunofluorescence	data	were	made	by	one-way	and	two-way	ANOVAs	followed	by	
Tukey’s	 post	 hoc	 test	 when	 necessary.	 The	 level	 of	 statistical	 significance	 was	 5%	
(p<0.05)	in	all	the	analyses.	
	
3. Results	
	
3.1. iTR	reduced	hyperalgesia	after	SNTR	
Changes	in	sensory	thresholds	were	recorded	at	both	medial	and	lateral	sites	of	the	
hindpaw	 to	 monitor	 the	 contribution	 to	 hyperalgesia	 of	 collateral	 sprouting	 of	
saphenous	nerve,	and	of	denervation	by	the	injured	sciatic	nerve	(Cobianchi	et	al.,	2013;	
Lopez-Alvarez	et	al.,	2015).	As	showed	in	Fig.	1A-B,	mechanical	and	thermal	thresholds	
in	 uninjured	 contralateral	 paws	 were	 not	 significantly	 affected	 by	 injury	 with	 an	
ipsi/contra%	threshold	ratio	of	about	100%	at	3	dpi.	However	SNTR	produced	a	marked	
decrease	of	the	mean	mechanical	threshold	at	the	medial	side	from	3	to	14	dpi	(Fig.	1A;	
48	 to	32%	of	contralateral	 in	SNTR-sed	group).	The	decrease	of	 thermal	 threshold	at	
medial	side	was	comparatively	lower	(Fig.	1B;	92	to	69%	in	SNTR-sed	group).	Statistical	
analyses	for	both	group	and	time	factors,	and	also	their	interaction,	showed	significant	
effects	 for	 the	changes	observed	 in	mean	medial	mechanical	 (Group	 factor:	F=26.39,	
p<0.0001;	Time	factor:	F=71.45,	p<0.0001;	Interaction:	F=9.35,	p<0.0001)	and	thermal	
thresholds	 (Group	 factor:	 F=17,	 p=0.0001;	 Time	 factor:	 F=4,	 p<0.0114;	 Interaction:	
F=8.83,	 p<0.0001).	 iTR	 significantly	 prevented	 the	 reduction	 of	 both	mechanical	 and	
thermal	thresholds	at	7	and	14	dpi	in	the	SNTR-iTR	group	(Fig.	1;	p<0.05	and	p<0.001,	
SNRT-iTR	vs.	SNRT-sed	Bonferroni	posttest).		
On	the	other	side,	the	lateral	side	of	the	injured	hindpaw	was	unresponsive	during	
the	14	days	following	SNTR,	since	this	territory	remains	denervated	until	at	least	4	weeks	
after	injury	(Cobianchi	et	al.,	2014).	Since	the	development	of	thermal	hyperalgesia	was	
slower	than	the	mechanical,	we	did	not	analyze	changes	of	thermal	thresholds	in	further	
experiments,	and	focused	on	the	changes	observed	at	the	medial	side	of	the	paw.	
	
3.2. iTR	counteracted	the	decrease	of	α1A	and	b2	adrenergic	and	5HT2A	serotonergic	
receptors	expression	in	the	dorsal	horn	after	SNTR	
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We	studied	the	expression	of	adrenergic	and	serotonergic	receptors	in	laminae	I,	II	
and	III	of	the	spinal	cord	dorsal	horn.	We	found	α1A	receptor	mainly	expressed	in	lamina	
II	and	at	lower	intensity	in	laminae	I	and	III	(Fig.	2A).	After	SNTR,	α1A	expression	strongly	
decreased	in	all	laminae	of	both	dorsal	horn	ipsilateral	and	contralateral	to	injury	(Fig.	
2A,B).	iTR	produced	an	increase	of	α1A	immunoreactivity	in	laminae	II-III	of	both	dorsal	
horns,	although	only	significantly	in	the	ipsilateral	side	(Fig.	2B;	p<0.001,	SNTR-iTR	vs.	
SNTR-sed).	On	the	other	hand,	the	expression	of	α2A	receptor	was	almost	unchanged	in	
the	dorsal	horn	of	injured	sedentary	and	exercised	rats	(data	not	shown).		
The	β2	receptor	was	expressed	in	all	laminae	I-III	of	the	dorsal	horn	in	the	naïve	rats	
(Fig.	 3A).	 SNTR	 reduced	 the	 expression	 of	 β2	 receptor	 in	 both	 the	 ipsilateral	 and	
contralateral	 sides	of	 lamina	 I,	 II	 and	 III	 (p<0.001	naive	 vs.	 SNTR-sed;	 Fig.	 3A,B).	 The	
expression	of	β2	was	significantly	recovered	by	iTR	in	the	lamina	II	bilaterally	(p<0.001	
SNTR-sed	vs.	SNTR-iTR)	and	in	the	contralateral	lamina	I	(p<0.01).		
In	naïve	animals,	the	5HT2A	receptor	was	more	densely	expressed	in	lamina	II,	even	
if	spot	clusters	of	immunofluorescent	labeling	were	present	in	all	dorsal	horn	laminae	
(Fig.	 4A).	 After	 SNTR,	 5HT2A	 immunoreactivity	 decreased	 significantly	 in	 lamina	 II	
bilaterally	(p<0.001	naive	vs.	SNTR-sed;	Fig.	4B)	and	in	the	ipsilateral	lamina	I	(p<0.05	
naive	vs.	SNTR-sed).	Interestingly,	iTR	significantly	recovered	5HT2A	receptor	expression	
in	lamina	II	(p<0.01	SNTR-sed	vs.	SNTR-iTR),	and	in	the	ipsilateral	lamina	I	(p<0.05,	SNTR-
sed	vs.	SNTR-iTR;	Fig.	4B).		
These	results	indicate	that	nerve	injury	determines	a	decrease	of	NE	and	5HT	tone	
in	 the	 dorsal	 horn	 neurons	 that	 may	 reflect	 the	 drive	 from	 normal	 to	 neuropathic	
conditions,	and	highlight	the	iTR	potential	to	reverse	these	changes.	
	
3.3. Changes	in	5HT2A,	α1A	and	β2	receptors	expression	in	midbrain	areas	induced	by	
SNTR	and	after	iTR	
Since	iTR	showed	to	significantly	impact	the	expression	of	5HT2A	serotonergic	and	
α1A	and	β2	adrenergic	receptors	in	the	lumbar	dorsal	horn	of	spinal	cord,	we	investigated	
the	 changes	 that	 peripheral	 nerve	 injury	 and	 iTR	 treatment	 determined	 on	 the	
expression	of	these	receptors	at	higher	integrating	brain	centers	that	participate	in	pain	
descending	modulation,	such	the	periaqueductal	grey	matter	(PAG),	the	locus	coeruleus	
(LC),	the	dorsal	raphe	(DRN)	and	the	raphe	magnus	nucleus	(RM)	(Fig.	5A).	
The	normal	expression	of	α1A	receptor	was	found	in	medium	to	large-size	neurons	
of	LC	and	DRN	and	on	terminals	of	NE	projections	to	RM	(Fig.	5B,	naïve	group).	Slightly	
stronger	 staining	was	 observed	 in	 the	DRN	 after	 injury	 (Fig.	 5B,	 SNTR-sed	 group),	 in	
contrast	with	the	reduced	expression	in	the	dorsal	horn.	iTR	significantly	increased	α1A	
immunoreactivity	 in	 LC	 and	 DRN,	 and	 in	 adjacent	 areas,	 such	 as	 the	 subcoeruleus	
nucleus,	 and	 in	more	 neurons	 of	 dorsomedial	 DRN	 areas	 (Fig.	 5B,	 SNTR-iTR	 group).	
Compared	with	LC	and	DRN,	where	the	increase	of	α1A	immunoreactivity	was	significant	
(Fig.	5C;	SNTR-iTR	vs.	naïve,	p<0.01,	and	SNTR-iTR	vs.	SNTR-sed,	p<0.05),	only	slightly	
increased	amount	of	 immunopositive	clusters	was	observed	surrounding	the	soma	of	
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RM	neurons.	The	changes	in	the	pattern	of	α1A	receptor	expression	across	LC	and	raphe	
nuclei	suggest	that	autologous	α1A	receptors	in	LC	may	have	been	activated	in	a	positive	
loop	to	increase	LC	activity	under	exercise	training.		
Autologous	β2	receptors	were	also	found	in	LC	and	sparse	immunoreactivity	in	DRN	
and	 RM	 of	 naïve	 rats	 (Fig.	 6A,	 naïve	 group).	 Nerve	 injury	 did	 not	 induce	 significant	
changes	in	β2	receptors	(Fig.	6A,	SNTR-sed	group).	iTR	rats	showed	immunoreactivity	in	
a	larger	area	of	LC	(Fig.	6A-B,	SNTR-iTR	vs.	SNTR-sed	p<0.01;	SNTR-iTR	vs.	naïve	p<0.05),	
and	 also	 a	 slight	 not	 significant	 higher	 density	 in	 DRN	 and	 RM,	 as	 terminals	 of	
noradrenergic	projections	from	LC	(Fig.	6B).	These	results	confirmed	that	iTR	enhanced	
the	activity	of	NE	LC	neurons.	
The	immunolabeling	of	5HT2A	receptor	in	naïve	rats	showed	positive	clusters	in	PAG	
and	DRN	 regions	 and	 rarely	 in	 the	 RM	nucleus	 extending	 laterally	 into	 the	 adjacent	
reticular	 formation,	where	are	 large-size	serotonergic	neurons	 (Fig.	7A,	naïve	group).	
Peripheral	nerve	injury	decreased	the	expression	of	5HT2A	in	PAG	and	DRN	(Fig.	7A-B,	
SNTR-sed	group).	The	pattern	of	expression	appeared	different	in	injured	animals,	with	
higher	presence	of	scattered	5HT2A	clusters	through	dorsomedial	areas	of	RM	than	in	
the	PAG	compared	with	naïve	samples.	iTR	strongly	increased	5HT2A	receptor	expression	
in	 PAG	 and	 DRN	 (Fig.	 7A-B,	 SNTR-iTR	 vs.	 SNTR-sed	 p<0.01,	 and	 SNTR-iTR	 vs.	 naïve	
p<0.05).	There	was	strong	immunolabeling	in	the	soma	of	many	large-size	neurons	in	
these	areas	and	even	in	dendrites	of	PAG	and	of	DRN	neurons	projecting	to	other	nuclei.	
Spot	clusters	indicating	terminal	5HT2A	contacts	were	significantly	increased	in	the	RM	
(Fig.	7A-B,	SNTR-iTR	vs.	SNTR-sed	p<0.05,	and	SNTR-iTR	vs.	naïve	p<0.01).	This	 result	
suggests	a	reorganization	of	serotonergic	connections	between	PAG	and	raphe	nuclei,	
with	the	possible	function	to	increase	their	activity	to	descending	output.		
	
3.4. Blockade	of	b2	or	5HT2A	receptors	antagonized	the	iTR	induced	hypoalgesia	after	
SNTR	
We	wanted	to	test	if	the	activation	of	β2	and	5HT2A	receptors	was	directly	involved	
in	the	prevention	of	mechanical	hyperalgesia	observed	in	iTR	rats	after	SNTR.	Inhibition	
of	 β2	 receptors	with	 butoxamine,	 a	 selective	 β2	 blocker,	 before	 starting	 iTR	 sessions	
antagonized	 its	 hypoalgesic	 effect	 at	 both	 7	 and	 14	 dpi	 (Fig.	 8A,	 SNTR-iTR	 vs.	 SNTR-
iTR+Bu	p<0.05).	However,	butoxamine	treatment	alone	had	no	effects	on	mechanical	
hyperalgesia,	indicating	a	specific	β2	activity	contribution	on	the	iTR	effects.		
Similarly,	treatment	with	ketanserin,	an	inhibitor	of	5HT2	receptors	(also	with	weak	
ɑ1	adrenergic	blocking	properties),	significantly	antagonized	the	iTR	hypoalgesic	effect,	
but	only	at	14	dpi	(Fig.	8B).	iTR	hypoalgesia	was	only	partially	blunted	at	7	dpi	(Fig.	8B,	
SNTR-iTR	 vs.	 SNTR-iTR+Ke,	 p<0.001	 at	 14	 dpi).	 Ketanserin	 treatment	 alone	 partially	
reduced	 SNTR	 induced	mechanical	 hyperalgesia,	 indicating	 that	 5HT2	 receptors	 (and	
maybe	ɑ1	receptors	blocked	by	ketanserin)	may	mediate	mechanisms	of	sensitization	
after	nerve	injury.	
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3.5. Depletion	of	NE	output	from	locus	coeruleus	with	DSP4	did	not	modify	the	
hypoalgesic	effect	of	iTR	
The	NE	specific	neurotoxin	DSP4	was	injected	to	induce	depletion	of	NE	projections	
from	 the	 LC	 (Grzanna	 et	 al.,	 1989),	 thus	 preventing	 the	 activation	 of	NE	 descending	
projections	during	iTR	(Fig.	9).	In	rats	receiving	DSP4	injection	the	hyperalgesia	was	even	
slightly	 increased	 compared	 with	 untreated	 rats	 (Fig.	 9A).	 However,	 iTR	 treatment	
similarly	 produced	 hypoalgesia	 in	 injured	 rats	 (p<0.01	 SNTR-iTR+DSP4	 vs.	 SNTR-
sed+DSP4),	despite	the	depletion	of	NE	output	significantly	reduced	the	expression	of	
β2	and	α1A	receptors	in	the	LC,	which	was	not	compensated	by	iTR	(Fig.	9B-C).	This	result	
suggests	 that	 the	 activation	 of	 NE	 descending	 projections	 may	 be	 not	 the	 only	
mechanism	inducing	pain	relief	by	iTR,	and	points	out	the	possibility	that	mesencephalic	
5HT	system	play	a	supportive	or	modulatory	role	for	NE.		
To	confirm	this	hypothesis,	we	looked	at	the	5HT2A	expression	in	LC.	Sparse	labeling	
of	5HT2A	receptors	was	found	in	the	LC	of	naïve	rats	(Fig.	10A),	probably	corresponding	
to	 terminals	 of	 PAG	 excitatory	 and	 DRN	 inhibitory	 projections	 that	 regulate	 the	 LC	
activity	(Haddjeri	et	al.,	1997;	Kim	et	al.,	2004).	SNTR	decreased	the	expression	of	5HT2A	
receptors,	which	was	prevented	in	the	groups	performing	iTR	(Fig.	10A-B).	The	inhibition	
of	β2	receptors	by	butoxamine	did	not	have	any	effect	on	the	expression	of	5HT2A	in	the	
LC	of	injured	rats.	In	contrast,	injection	of	DSP4	induced	a	significant	increase	of	5HT2A	
immunoreactivity	 (p<0.01	and	0.05	SNTR-sed	vs.	SNTR-sed+DSP4	and	SNTR-iTR+DSP4	
respectively),	even	higher	than	by	iTR	alone.	The	strong	effect	induced	by	DSP4	on	the	
expression	of	5HT2A	receptors	may	suggest	the	activation	of	DRN	5HT	to	increase	the	
inhibition	of	depleting	LC	neurons,	while	iTR	exercise	seems	to	restore	the	normal	tonic	
PAG	and	DRN	5HT	control	on	NE	activity.	All	together	these	results	demonstrate	that	iTR	
hypoalgesia	is	conveyed	by	both	β2	and	5HT2A	receptors	likely	through	parallel	activation	
of	5HT2A	in	PAG	and	DRN	along	to	adrenergic	LC	neurons	to	balance	the	impairment	of	
their	activity	due	to	injury.	
	
3.6. iTR	reduced	microgliosis	in	locus	coeruleus	dependent	on	activation	of	β2	receptor	
after	SNTR	
Since	activation	of	microglia	has	been	described	to	be	regulated	by	β2	adrenergic	
receptor	activation	(Fujita	et	al.,	1998;	O’Donnell	et	al.,	2012),	and	plays	an	active	role	
in	 the	 pathway	 that	 leads	 to	 BDNF	 regulation	 and	 KCC2	 dephosphorylation	 in	
neuropathic	pain	states	(Modol	et	al.,	2014),	we	evaluated	the	microglial	activation	after	
SNTR	 (Fig.	 11).	We	 focused	 in	 LC	 in	 order	 to	 analyze	 the	 reaction	 of	microglial	 cells	
adjacent	to	noradrenergic	neurons	projecting	to	the	spinal	cord.	Iba1	immunoreactivity	
in	the	LC	showed	significant	microglia	activation	after	nerve	injury	compared	to	naïve	
rats	(Fig.	11A-B,	p<0.01,	naïve	vs.	SNTR-sed).	Interestingly,	iTR	significantly	reduced	Iba1	
immunoreactivity	 (p<0.05,	 SNTR-sed	 vs.	 SNTR-iTR).	 However,	 the	 effect	 of	 iTR	 was	
reverted	by	butoxamine	injection	(p<0.001,	naïve	vs.	SNTR-sed+Bu	and	SNTR-iTR+Bu).	
Butoxamine	 treated	 groups	 showed	 highly	 ramified	 microglial	 cells	 suggesting	 that	
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inhibition	of	β2	receptors	may	favor	proliferation	of	microglia	(Fig.	11A).	These	results	
show	 that	 β2	 receptors	 are	 involved	 in	 the	 iTR	 reduction	of	microglial	 reaction	 after	
nerve	 injury	 in	 the	 LC,	 and	 this	 mechanism	 could	 represent	 a	 potential	 shift	 from	
hyperalgesic	to	hypoalgesic	state.	
Since	the	expression	of	injury-induced	microglial	BDNF	reactivity	in	the	spinal	cord	
dorsal	horn	neurons	is	associated	to	neuropathic	pain	and	is	reduced	by	iTR	(Cobianchi	
et	 al.,	 2013;	 Lopez-Alvarez	 et	 al.,	 2015;	 Udina	 et	 al.,	 2011),	 we	 also	 analyzed	 BDNF	
expression	 in	 the	 LC.	 BDNF	 immunoreactivity	was	 scant	 in	 LC	 of	 naïve	 rats,	 and	 not	
colocalized	with	 Iba1	 (Fig.	 11A,	 naïve	 group).	 The	 level	 of	 BDNF	 expression	was	 not	
influenced	by	nerve	injury,	but	it	was	present	in	reactive	microglia	(Fig.	11A,	SNTR-sed	
group),	and	increased	above	normal	levels	by	iTR	(Fig.	11A,	SNTR-iTR	group).	In	contrast,	
BDNF	immunoreactivity	was	lowered	by	butoxamine	treatment	(Fig.	11A,	SNTR-sed+Bu	
and	SNTR-iTR+Bu),	although	changes	were	not	significant	between	the	different	groups	
(Fig.	11B).	This	result	shows	that	iTR	increases	BDNF	expression	in	midbrain	areas	but	
not	dependent	on	β2	receptors	differently	from	the	activation	of	microglia.	
	
4. Discussion	
In	 this	 study	 we	 aimed	 to	 analyze	 the	 contribution	 of	 5HT	 and	 NE	 descending	
pathways	to	the	hypoalgesic	effect	of	iTR	on	peripheral	neuropathic	pain.	We	showed	
that	iTR	reduced	hyperalgesia	was	associated	with	parallel	recovery	in	the	expression	of	
serotonergic	5HT2A	and	noradrenergic	α1A	and	β2	receptors	in	sensory	neurons	of	lumbar	
spinal	cord	and	in	brainstem	areas	known	to	integrate	sensory	and	motor	inputs	in	order	
to	modulate	the	descending	responses.		
The	immunohistochemical	characterization	of	NE	receptors	expression	in	spinal	cord	
dorsal	horn	revealed	that	they	are	mainly	expressed	in	laminae	II-III,	where	they	were	
reduced	after	SNTR.	The	recovery	of	α1A	and	β2	but	not	of	α2A	receptors	observed	after	
iTR	may	be	related	to	the	inhibition	of	the	afferent	pain.	Baba	et	al.	(2000)	demonstrated	
the	 contribution	 of	 α1	 receptors	 to	 antinociception	 by	 activation	 of	 GABAergic	 and	
glycinergic	inhibitory	interneurons.	Our	results	suggest	that	the	downregulation	of	α1A	
receptor	 in	 dorsal	 horn	 interneurons	 contributes	 to	 hyperexcitability	 and	 spinal	
disinhibition	after	peripheral	nerve	injury.	iTR	training	upregulated	the	α1A	receptor	in	
the	lamina	II,	a	region	rich	of	GABAergic	and	glycinergic	interneurons,	thus	promoting	
their	inhibitory	action.	
iTR	also	reverted	the	reduction	of	β2	receptor,	particularly	in	lamina	II	of	the	dorsal	
horn.	The	β2	receptor	is	present	in	the	central	terminals	of	nociceptive	afferents	and	on	
dendrites	 of	 superficial	 dorsal	 horn	 neurons	 (Nicholson	 et	 al.,	 2005;	 Patterson	 and	
Hanley,	1987;	Mizukami,	2004).	Interestingly	capsaicin	treatment	in	rats	decreased	the	
β	adrenergic	binding	sites	in	the	spinal	cord	(Patterson	and	Hanley,	1987),	as	we	have	
found	 after	 sciatic	 nerve	 injury.	 The	 facts	 that	 iTR	 increased	β2	 expression,	 and	 that	
inhibition	of	β2	with	butoxamine	antagonized	the	hypoalgesic	effect	of	exercise,	support	
the	view	that	β2	receptor	is	contributing	to	mediate	the	hypoalgesia	induced	by	iTR.	This	
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suggestion	is	in	line	with	the	antiallodynic	effect	demonstrated	by	Yalcin	et	al.	(2009a,b,	
2010)	by	pharmacological	stimulation	of	β2	after	sciatic	lesion.	
Activation	of	5HT2A	receptor	is	known	to	enhance	glycine	and/or	GABA	responses	
in	spinal	neurons	(Xu	et	al.,	1996;	Liu	et	al.,	2000),	and	to	shift	the	chloride	equilibrium	
potential	 in	 the	 hyperpolarizing	 direction	 (Bos	 et	 al.,	 2013),	 restoring	 endogenous	
inhibition	 at	 the	 dorsal	 horn.	 We	 have	 found	 that	 iTR	 increased	 5HT2A	 expression,	
suggesting	that	activation	of	5HT2A	mediated	tonic	inhibition	may	contribute	to	the	iTR	
effect	on	reducing	hyperalgesia	after	nerve	injury.	However,	an	increase	in	dorsal	horn	
5HT2A	density	was	reported	in	a	model	of	persistent	pain	(Van	Steenwinckel	et	al.,	2009),	
and	 upregulation	 and	 activation	 of	 5HT2A	 was	 observed	 after	 spinal	 nerve	 ligation,	
associated	to	spinal	hyperexcitability	(Aira	et	al.,	2010).	Furthermore,	administration	of	
a	selective	5HT2A	agonist	in	the	spinal	nerve	ligation	model	significantly	increased	C-fiber	
evoked	potentials	(Aira	et	al.,	2010).	
On	 the	 other	 hand,	 we	 showed	 that	 immunoreactivity	 to	 5HT2A	 after	 SNTR	
significantly	decreased	 in	 laminae	I-III,	similarly	to	β2	receptor,	and	the	prevention	of	
5HT2A	receptor	activation	during	exercise	by	pretreatment	with	ketanserin	reduced	the	
iTR	hypoalgesic	 effect.	 Then	 if	 restoration	of	both	 spinal	 5HT2A	 and	β2	 receptors	 is	 a	
direct	consequence	of	iTR,	5HT2A	may	be	not	directly	involved	as	β2	in	the	mechanism	of	
early	pain	suppression.	This	may	be	explained	by	the	multiple	roles	that	5HT2A	receptor	
may	 play	 on	 neuropathic	 pain	 conditions,	 by	 differently	 acting	 on	 neuronal	
subpopulations	of	dorsal	horn	to	inhibit	or	facilitate	pain	signals.	After	injury,	a	shift	of	
5HT2A	 receptors	 to	 inhibitory	 interneurons	 was	 shown	 (Aira	 et	 al.,	 2010).	 Since	 iTR	
counteracted	 the	 spinal	 loss	 of	 5HT2A,	 we	 suggest	 that	 our	 treadmill	 protocol	 may	
potentiate	the	activity	of	inhibitory	interneurons	that	intervene	in	nociception.		
Besides	 changes	 in	 the	 spinal	 cord,	 antinociception	may	 be	 conveyed	 by	 iTR	 by	
activation	of	 5HT2A	 receptor	 as	well	 as	 adrenoreceptors	 at	higher	brain	 centers.	 It	 is	
known	that	projections	from	PAG-RM	and	LC	to	the	spinal	cord	play	a	pivotal	role	in	pain	
control.	Pain	and	temperature	fibers	project	to	PAG	through	the	spinomesencephalic	
tract,	 and	PAG	 can	 control	 afferent	pain	by	means	of	 parallel	 actions	on	RM	and	 LC	
(Basbaum	 and	 Fields,	 1978).	 In	 these	 nuclei,	 antinociceptive	 mechanisms	 can	 be	
activated	through	μ1	opioid,	5HT2A	and	5HT2C	serotonergic,	and	α1A	adrenergic	receptors	
of	 the	 LC	 (de	 Freitas	 et	 al.,	 2016).	 β2	 receptor	 is	 also	 expressed	 in	 areas	 directly	
participating	in	pain	(Nicholson	et	al.,	2005),	and	human	genetic	studies	confirmed	the	
contribution	 of	 β2	 to	 chronic	 pain	 disorders	 (Diatchenko	 et	 al.,	 2006).	Moreover,	 β2	
receptor	is	essential	for	the	antiallodynic	action	of	antidepressant	drugs	(Yalcin	et	al.,	
2009a,b),	 since	 the	 absence	 or	 blockade	 of	 β2	 suppressed	 the	 hypoalgesic	 effect	 of	
antidepressant	drugs	on	mechanical	allodynia	(Yalcin	et	al.,	2009b).		
The	actions	played	by	iTR	on	mesencephalic	nuclei	to	activate	central	pain	control	
may	 be	 multiple,	 and	 conveyed	 through	 synaptic	 regulation	 of	 NE	 and	 5HT	
interconnections.	 Indeed,	PAG	 is	known	also	 to	be	excited	or	 inhibited	by	5HT2A	and	
5HT1A	receptors	expressing	fibers	from	DRN,	which	form	a	regulatory	circuitry	negatively	
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modulated	by	GABA	and	opioids	(Jolas	and	Aghajanian,	1997;	Liu	et	al.,	2000).	The	DRN	
is	the	 largest	serotonergic	nucleus	providing	most	supply	of	5HT	to	forebrain,	and	 its	
dorsal	subnuclei	are	located	adjacent	to	the	PAG,	where	dense	clusters	of	5HT	neurons	
project	to	the	RM	(Kwiat	and	Basbaum,	1990;	Cho	and	Basbaum,	1991)	and	to	the	LC	
(Kim	et	al.,	2004).	Activation	of	the	brainstem	5HT	system	modulates	both	nociceptive	
and	motor	spinal	cord	circuits	(Jordan	and	Slawinska,	2011;	Pearlstein	et	al.,	2005),	and	
exercise	 increases	 the	 release	 of	 5HT	 in	 supraspinal	 areas	 associated	 to	 reducing	
mechanical	hyperalgesia	(Gerin	et	al.,	2008;	Korb	et	al.,	2010;	Jacobs	et	al.,	2002).	In	a	
recent	 work,	 Bobinski	 et	 al.	 (2015)	 found	 increased	 brainstem	 levels	 of	 5HT,	 its	
metabolites	and	5HT1B/2A/2C	 receptors	after	a	2-weeks	 low-intensity	 treadmill	 training	
following	 sciatic	 nerve	 injury.	 Interestingly,	 the	 inhibition	 of	 5HT	 but	 not	 of	
catecholamines	 reversed	 the	 hypoalgesic	 effect	 of	 such	 low-intensity	 exercise.	 At	
difference,	 our	 study	 suggests	 that	 NE	 antinociception	 can	 be	 further	 activated	 by	
increasing	the	intensity	of	exercise.	Indeed,	the	iTR	training	induced	an	increase	of	α1A,	
β2	and	5HT2A	receptors	expression	in	the	PAG-DRN	and	PAG-LC	pathways.	5HT	and	NE	
systems	may	 interact	 in	 these	areas	during	exercise.	Earlier	 studies	 revealed	 that	NE	
causes	 an	 increase	 in	 5HT	 neuronal	 firing	 in	 DRN,	 mediated	 via	 activation	 of	 α1	
adrenoceptor	located	on	5HT	neurons	(Day	et	al.,	1997;	Vandermaelen	and	Aghajanian,	
1983).	We	hypothesize	that	the	activation	of	α1A	receptor	in	the	DRN	may	form	part	of	
a	regulatory	loop	that	is	activated	by	iTR	between	DRN	and	LC	to	enhance	LC	and	RM	
descending	 pain-suppressing	 neurons.	 NE	 axons	 could	 also	 activate	 α1	 receptors	 on	
GABAergic	 and	 glycinergic	 inhibitory	 interneurons	 leading	 to	 inhibition	 of	 pain-relay	
neurons	(Pertovaara,	2006).	
On	 the	 other	 hand,	 pharmacological	 stimulation	 of	 β2	 receptor	 suppressed	
neuropathic	pain	after	sciatic	nerve	insult	(Yalcin	et	al.,	2010).	We	found	that	iTR	strongly	
increased	the	expression	of	β2	receptor	in	the	dorsal	horn	lamina	II	interneurons	and	in	
the	LC,	and	that	activation	of	β2	receptor	was	necessary	to	induce	iTR	hypoalgesia.	To	
understand	which	part	of	this	circuitry	is	involved	in	the	hypoalgesic	effect,	we	depleted	
the	NE	output	from	LC	by	using	the	neurotoxin	DSP4	(Jonsson	et	al.,	1981;	Prieto	and	
Giralt,	 2001).	 Administration	 of	 DSP4	 has	 been	 shown	 to	 revert	 antinociception	 in	
different	pain	models	(Zhong	et	al.,	1985;	Kudo	et	al.,	2010)	and	to	regulate	5HT	agonists	
induced	analgesia	(Garcia	et	al.,	2003).	In	our	model,	pretreatment	with	DSP4	increased	
the	hyperalgesia	but	did	not	block	the	effect	of	iTR.	Since	the	activity	of	LC	neurons	is	
subordinated	to	the	activation	of	5HT	projections	from	PAG	and	DRN,	we	suggest	that	
iTR	training	can	trigger	NE-induced	descending	inhibition	by	reestablishing	also	5HT2A	
receptor	 activity	 in	 the	 brainstem.	 Our	 results	 highlight	 the	 5HT	 and	 NE	 reciprocal	
actions	under	neuropathic	pain	and	blockade	of	NE	neurons.		
Brain	and	spinal	expression	of	neurotrophins,	particularly	BDNF,	can	be	modulated	
by	 activation	 of	 NE	 and	 5HT	 pathways,	 with	 relevant	 effects	 on	motor	 and	 sensory	
recovery	 after	 nerve	 injuries.	 NE	 activation	 via	 β	 adrenergic	 receptors	 seems	 to	 be	
essential	 for	exercise-induced	BDNF	regulation	(Garcia	et	al.,	2003),	and	β	adrenergic	
14	
	
blockade	 significantly	 attenuates	 the	 increase	 of	 BDNF	mRNA	due	 to	 exercise	 in	 the	
cortex	(Ivy	et	al.,	2003).	On	the	other	hand,	BDNF	released	by	activated	microglia	triggers	
neuropathic	mechanisms,	such	as	downregulation	of	chloride	cotransporter	KCC2	(Coull	
et	 al.,	 2005;	 Ferrini	 and	 De	 Koninck,	 2013),	 associated	 to	 disinhibition	 at	 spinal	
interneurons	(Modol	et	al.,	2014).	iTR	increased	the	BDNF	expression	in	LC	parallel	to	
decreasing	 microgliosis	 and	 BDNF-expressing	 microglia,	 as	 we	 previously	 showed	 in	
association	to	the	recovery	of	KCC2	levels	(Lopez-Alvarez	et	al.,	2015).	The	blockade	of	
β2	receptor	also	increased	microgliosis,	suggesting	that	activation	of	β2	receptor	during	
iTR	plays	a	role	in	modulation	of	the	neuroinflammatory	response	to	nerve	injury.	5HT2A	
receptor	activity	has	been	described	to	downregulate	the	BDNF	expression	 in	the	rat	
brain	(Vaidya	et	al.,	1997).	The	reduction	of	neurotrophins	NGF	and	BDNF	observed	in	
DRG	sensory	neurons	after	iTR	(Cobianchi	et	al.,	2013;	Lopez-Alvarez	et	al.,	2015)	could	
be	associated	to	the	sustained	increase	of	β2	and	5HT2A	receptors	expression	in	brain	
and	spinal	cord,	which	are	reduced	by	sciatic	nerve	injury.	These	results	indicate	that	
the	increased	neurotrophic	factor	production	in	sensory	neurons	after	peripheral	nerve	
injury	can	be	reversely	modulated	by	 increased	intensity	exercise	 in	order	to	prevent	
maladaptive	plastic	changes	associated	to	neuropathic	pain.	
	
5. Conclusions	
The	results	of	this	study	bring	new	knowledge	on	the	contribution	of	descending	
inhibition,	 by	 increasing	 activity	 of	 serotonergic	 and	 noradrenergic	 projections	 from	
brainstem	 centers,	 to	 the	 beneficial	 effects	 of	 specific	 exercise	 training	 programs	 in	
reducing	 neuropathic	 pain.	 Future	 studies	 aimed	 at	 understanding	 which	 neuronal	
populations	 and	which	molecular	mechanisms	underlying	 pain	 inhibition	 and	 central	
brainstem	 circuits	 are	 still	 needed	 to	 foster	 the	 therapeutic	 possibilities	 for	 treating	
sensorimotor	disorders	with	specific	exercise	programs.	
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Figure	 1.	Hyperalgesia	 is	 reduced	 by	 iTR	 after	 SNTR.	 Changes	 in	mechanical	 (A)	 and	
thermal	 (B)	sensory	 thresholds	 recorded	at	 the	medial	 (filled	colour	bars)	and	 lateral	
(dotted	colour	bars)	test	sites	in	rats	after	SNTR	that	were	untrained	(-sed)	or	followed	
daily	iTR	from	3	days	(-iTR).	Values	are	represented	as	the	percent	ratio	between	the	
mean	ipsilateral	and	the	contralateral	paw	threshold	at	3,	7	and	14	days	post-injury	(dpi).	
*	p<0.05,	***	p<0.001.	
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Figure	2.	iTR	counteracted	the	decrease	of	α1A	receptor	expression	in	dorsal	horn	after	
SNTR.	(A)	Representative	confocal	images	of	α1A	adrenergic	receptor	immunoreactivity	
at	 14	 dpi	 in	 the	 spinal	 dorsal	 horn	 of	 naïve	 rats,	 and	 in	 the	 ipsilateral	 (ipsi)	 and	
contralateral	 (contra)	 dorsal	 horns	 of	 SNTR-sed	 and	 SNTR-iTR	 rats,	 with	 graphic	
representation	of	laminae	I-IV	as	regions	of	interest	included	in	captured	images.	Scale	
bar	100μm.	(B)	Quantification	of	α1A	immunoreactivity	in	the	ipsilateral	and	contralateral	
dorsal	horn	laminae	(I,	II,	III)	of	SNTR-sed	and	SNTR-iTR	rats	compared	with	to	naïve	rats.	
**	p<=0.01,	***	p<0.001.		
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Figure	3.	 iTR	counteracted	the	decrease	of	β2	receptor	expression	in	dorsal	horn	after	
SNTR.	 (A)	 Representative	 confocal	 images	 of	 the	 β2	 adrenergic	 receptor	
immunoreactivity	at	14	dpi	in	the	spinal	dorsal	horn	of	naïve	rats,	and	in	the	ipsilateral	
(ipsi)	and	contralateral	(contra)	dorsal	horns	of	SNTR-sed	and	SNTR-iTR	rats,	with	graphic	
representation	of	laminae	I-IV	as	regions	of	interestincluded	in	captured	images.	Scale	
bar	100μm.	(B)	Quantification	of	β2	immunoreactivity	in	the	ipsilateral	and	contralateral	
dorsal	horn	laminae	(I,	II,	III)	of	SNTR-sed	and	SNTR-iTR	rats	compared	to	naïve	rats.	**	
p<=0.01,	***	p<0.001.		
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Figure	4.	iTR	counteracted	the	decrease	of	5HT2A	receptor	expression	in	dorsal	horn	after	
SNTR.	 (A)	 Representative	 confocal	 images	 of	 the	 5HT2A	 serotonergic	 receptor	
immunoreactivity	at	14	dpi	in	the	spinal	dorsal	horn	of	naïve	rats,	and	in	the	ipsilateral	
(ipsi)	and	contralateral	(contra)	dorsal	horns	of	SNTR-sed	and	SNTR-iTR	rats,	with	graphic	
representation	of	laminae		I-IV	as	regions	of	interestincluded	in	captured	images.	Scale	
bar	 100μm.	 (B)	 Quantification	 of	 5HT2A	 immunoreactivity	 in	 the	 ipsilateral	 and	
contralateral	dorsal	horn	laminae	(I,	II,	III)	of	SNTR-sed	and	SNTR-iTR	rats	compared	to	
naïve	rats.	*	p<0.001,	**	p<=0.01,	***	p<0.001.		
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Figure	5.	iTR	increased	the	expression	of	5HT2A	receptor	in	PAG,	DRN	and	RM	after	SNTR.	
(A)	Graphic	 representation	 of	 PAG,	 RM,	DRN	 and	 LC	 nuclei	 considered	 as	 regions	 of	
interest	for	quantification	in	coronal	sections.	(B)	Representative	confocal	images	of	the	
5HT2A	serotonergic	receptor	immunoreactivity	at	14	dpi	in	PAG,	DRN	and	RM	of	naïve,	
SNTR-sed	 and	 SNTR-iTR	 rats.	 Scale	 bar	 100μm.	 (C)	 Quantification	 of	 5HT2A	
immunoreactivity	 in	 PAG,	DRN	 and	RM	of	 SNTR-sed	 and	 SNTR-iTR	 rats	 compared	 to	
naïve	rats.	*	p<0.05;	**	p<0.01.		
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Figure	6.	 iTR	 increased	 the	 expression	of	α1A	 receptor	 in	 LC	and	DRN	after	 SNTR.	 (A)	
Representative	confocal	images	of	the	α1A		receptor	immunoreactivity	at	14	dpi	in	LC,	
DRN	and	RM	of	naïve,	SNTR-sed	and	SNTR-iTR	rats.	Scale	bar	100μm.	(B)	Quantification	
of	α1A	immunoreactivity	in	LC,	DRN	and	RM	of	SNTR-sed	and	SNTR-iTR	rats	compared	to	
naïve	rats.	*	p<0.05;	**	p<0.01.		
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Figure	7.	iTR	increased	the	expression	of	β2	receptor	in	LC	after	SNTR.	(A)	Representative	
confocal	images	of	the	β2	adrenergic	receptor	immunoreactivity	at	14	dpi	in	LC,	DRN	and	
RM	of	 naïve,	 SNTR-sed	 and	 SNTR-iTR	 rats.	 Scale	 bar	 100μm.	 (B)	Quantification	of	 β2	
immunoreactivity	in	LC,	DRN	and	RM	of	SNTR-sed	and	SNTR-iTR	rats	compared	to	naïve	
rats.	*	p<0.05;	**	p<0.01.		
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Figure	8.	Blockade	of	β2	or	5HT2A	 receptors	antagonized	 the	 iTR	 induced	hypoalgesia	
after	SNTR.	 (A-B)	Changes	 in	mechanical	 threshold	of	SNTR-sed	and	SNTR-iTR	groups	
compared	with	rats	treated	with	Butoxamine	(A,	SNTR-sed+Bu	and	SNTR-iTR+Bu	groups)	
or	Ketanserin	(B,	SNTR-sed+Ke	and	SNTR-iTR+Ke	groups),	recorded	at	medial	test	sites	
at	3,	7	and	14	days	post-injury	(dpi)	and	represented	as	the	percent	ratio	between	the	
ipsilateral	and	the	contralateral	paw.	*	p<0.05;	**	p<0.01;	***	p<0.001.	
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Figure	 9.	Depletion	 of	 NE	 output	 from	 locus	 coeruleus	 with	 DSP4	 did	 not	 affect	 the	
hypoalgesic	effect	of	iTR.	(A)	Changes	in	mechanical	threshold	of	SNTR-sed	and	SNTR-
iTR	groups	compared	with	rats	treated	also	with	DSP4,	recorded	at	medial	test	sites	at	
3,	7	and	14	days	post-injury	 (dpi)	and	 represented	as	 the	percent	 ratio	between	 the	
ipsilateral	and	the	contralateral	paw.	(B)	Representative	confocal	images	of	α1A	and	β2	
adrenergic	receptors	immunoreactivity	at	14	dpi	in	LC	of	SNTR-sed,	SNTR-sed+DSP4	and	
SNTR-iTR+DSP4	rats.	Scale	bar	100μm.	(C)	Quantification	of	α1A	and	β2	immunoreactivity	
in	LC	of	SNTR-sed	and	SNTR-iTR	groups	compared	with	rats	treated	with	DSP4	(SNTR-
sed+DSP4	and	SNTR-iTR+DSP4	groups).	*	p<0.05;	**	p<0.01;	***	p<0.001.		
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Figure	10.	The	expression	of	5HT2A	receptor	in	locus	coeruleus	was	normalized	by	iTR	and	
further	increased	by	DSP4	injection	after	SNTR.	(A)	Representative	confocal	 images	of	
the	5HT2A	serotonergic	receptor	immunoreactivity	at	14	dpi	in	LC	of	naïve,	SNTR-sed	and	
SNTR-iTR	rats,	and	those	treated	with	Butoxamine	or	with	DSP4.	Scale	bar	100μm.	(B)	
Quantification	of	5HT2A	immunoreactivity	in	LC	of	naïve,	SNTR-sed	and	SNTR-iTR	groups	
compared	with	the	same	groups	treated	also	with	Butoxamine	(SNTR-sed+Bu	and	SNTR-
iTR+Bu	 groups)	 or	 DSP4	 (SNTR-sed+DSP4	 and	 SNTR-iTR+DSP4	 groups).	 *	 p<0.05;	 **	
p<0.01.		
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Figure	 11.	 iTR	 reduced	microgliosis	 in	 locus	 coeruleus	 dependent	 on	 activation	 of	 β2	
receptor	 after	 SNTR.	 (A)	 Representative	 confocal	 images	 of	 Iba1	 and	 BDNF	
immunoreactivity	at	14	dpi	in	LC	of	naïve,	SNTR-sed	and	SNTR-iTR	groups	compared	with	
groups	treated	also	with	Butoxamine	(SNTR-sed+Bu	and	SNTR-iTR+Bu	groups).	Yellow	
arrows	point	to	microglial	cells	expressing	BDNF;	red	arrows	point	to	BDNF	labeling	not	
colocalized	with	 Iba1.	 Scale	bar	100μm.	 (B)	Relative	quantification	of	 Iba1	and	BDNF	
immunoreactivity	 (Integrated	Density,	 InDen)	 in	 double-labeled	 LC	 samples	 of	 naïve,	
SNTR-sed	and	SNTR-iTR	rats	compared	with	rats	treated	also	with	Butoxamine	(SNTR-
sed+Bu	and	SNTR-iTR+Bu	groups).	*	p<0.05;	**	p<0.01;	***	p<0.001.		
	
	
